A familiar clinic name does not tell you who will make your prescribing decision. Before starting a sermorelin program, ask for the clinician’s full name, professional credential, and the practice responsible for your care. A customer-service representative and a licensed prescriber have different jobs.

You can use public regulatory records to check important facts without relying on a website badge. Those records can establish license information; they cannot guarantee that a treatment will work or that a particular clinician is the right match for your needs.

The considered take

Check the person and the relevant state authority, then ask how that person will evaluate and follow you.

Start with the person who will review your history

Ask whether your assessment will be performed by a physician, nurse practitioner, or physician assistant. Request the full professional name rather than a first name or a photograph from a general team page. If assignment happens after registration, ask when you can see that information and what charges arise beforehand.

The prescription guide explains the larger process. Knowing the clinician's identity lets you connect a proposed prescription to a real professional record. A medical director pictured on a website may not be the individual reviewing your intake.

Sources: FSMB: Information for consumers · FDA: Managing the benefits and risks of medicines

Use the licensing authority for that profession

FSMB directs consumers to state medical boards and its DocInfo service for physician licensure and disciplinary information. Start with an official record and match the full name carefully. Read license status and any linked public orders in context; similar names can belong to different people.

For other professions, use the applicable state regulator and credential category rather than assuming a physician search covers everyone. If the record is unclear, ask the regulator how to interpret it. A search with no match is a reason to resolve identity and jurisdiction, not enough by itself to accuse someone of practicing without authority.

Sources: FSMB: Information for consumers · HHS: Telehealth licensing across state lines

An NPI is an identifier, not a license check

CMS explicitly cautions that issuing an NPI does not validate a provider's license or credentials. Finding an NPI can help distinguish records, but the number does not replace checking the relevant licensing authority. It also does not establish specialist training or an endorsement of sermorelin.

Keep these questions separate: who is this person, what authority do they have to practice here, and what experience is relevant to my problem? An online profile can help you organize those questions, but it should not collapse all three into a single verification badge.

Sources: CMS: NPI records and credential limitation · FSMB: Information for consumers

Check where you will physically be during the visit

HHS advises providers to verify the patient's location before telehealth appointments. A clinician's authority to see you can depend on that location and the available state licensing pathway. Having a home address on file does not settle an appointment taken while traveling.

Our cross-state telehealth guide covers that situation. Tell the practice about a temporary stay or move before the appointment. Ask it to confirm the clinician's authority for that visit instead of assuming that a national website means every clinician can treat patients everywhere.

Sources: HHS: Telehealth licensing across state lines · HHS: Telehealth legal considerations

Ask how a prescription decision will be reached

A license check does not answer whether your symptoms justify hormone treatment. Ask which history, examination, records, or tests the clinician needs, what other explanations they will consider, and what would lead them to recommend against sermorelin. The answer should be more specific than approval being easy.

The consultation checklist and adult growth hormone deficiency guide explain those clinical questions. A prescriber should also discuss uncertainties around the proposed compounded medicine. Regulatory identity and medical evidence are different parts of an informed choice.

Sources: Endocrine Society: Adult growth hormone deficiency · FDA: Compounding questions and answers · FDA: Managing the benefits and risks of medicines

Verify the follow-up arrangement separately

Find out who receives messages after prescribing, how to reach a clinician about a new symptom, and what happens if the original professional leaves the service. Ask how your usual clinician can receive records and whether additional visits cost extra. Save the contact details in a place you can find easily.

The dispensing pharmacy needs its own check, too. Our compounding pharmacy guide addresses that separate role. A qualified prescriber, identifiable pharmacy, and workable follow-up plan each answer a different question; none should disappear behind the brand's checkout screen.

Sources: FDA: Managing the benefits and risks of medicines · HHS: your medical records · FDA: Compounding questions and answers

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. FSMB: Information for consumersGovernment or medical organization guidance · Licensure and disciplinary information through state boards and DocInfo. Checked September 22, 2026.
  2. FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
  3. HHS: Telehealth licensing across state linesUS government guidance · Licensure options depend on the patient location and state rules.
  4. CMS: NPI records and credential limitationGovernment or medical organization guidance · An NPI does not itself validate licensing or credentials. No dataset downloaded. Checked September 22, 2026.
  5. HHS: Telehealth legal considerationsGovernment or medical organization guidance · General licensing, consent, and privacy guidance; state-specific verification remains necessary. Checked September 22, 2026.
  6. Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
  7. FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
  8. HHS: your medical recordsUS government · Patient access and correction rights; not a guarantee of prescription transfer or continuation. Checked September 21, 2026.